The Antitumor Activity of TCR-Mimic Antibody-Drug Conjugates (TCRm-ADCs) Targeting the Intracellular Wilms Tumor 1 (WT1) Oncoprotein
International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms20163912
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 12, 2019
Authors
Publisher
MDPI AG